Baird Financial Group Inc. reduced its stake in Merck & Co., Inc. by 8.5% in the second quarter, selling 98,410 shares but still retaining over 1 million shares valued at approximately $136.8 million. The article details other institutional investor activity, analyst ratings, and key news impacting Merck, including the importance of Keytruda and the upcoming patent expiration. Despite some concerns about valuation and Gardasil sales, analysts maintain a "Moderate Buy" rating with an average price target of $149.80.

Baird Financial Group Inc. significantly increased its stake in Parker-Hannifin Corporation by 2.1% in the second quarter, now owning 893,395 shares valued at approximately $873.8 million. This makes Parker-Hannifin the 19th largest holding for Baird Financial Group. Institutional investors collectively hold 82.44% of the company, and analysts maintain a "Moderate Buy" rating with an average target price of $1,114.55.

Ameritas Advisory Services LLC significantly increased its stake in The Goldman Sachs Group, Inc. (NYSE:GS) by 212.7% during the second quarter, now owning 3,227 shares valued at $3.26 million. The article also highlights other institutional investors modifying their holdings, details Goldman Sachs' recent financial performance, including exceeding earnings estimates and increasing its dividend, and discusses key headlines impacting the company.

ADAR1 Capital Management, a 10% owner of Tenax Therapeutics (NASDAQ: TENX), recently invested approximately $1.6 million by purchasing 900,000 shares. This insider buying occurred while the stock was trading significantly below its 52-week high, with InvestingPro analysis suggesting it is currently undervalued. The company has also been the subject of recent analyst updates, including both price target reductions due to disappointing clinical trial results and new "Outperform" ratings based on potential future trial success.

Amundi increased its stake in The Hershey Company (NYSE:HSY) by 21.9% in the second quarter, bringing its total holdings to 1,040,305 shares valued at $182.52 million. Other institutional investors also adjusted their positions in Hershey, and analysts have issued a consensus "Hold" rating with an average price target of $204.78 for the stock. Hershey recently reported strong quarterly earnings, surpassing analyst expectations, and declared a quarterly dividend.

Allianz Asset Management GmbH significantly reduced its stake in The Hershey Company (NYSE:HSY) by 72.6% in Q2, selling 55,711 shares to hold 21,020 shares worth $3.688 million. Despite this, other institutional investors increased their holdings, and 57.96% of the stock is owned by hedge funds. Hershey recently reported strong Q2 earnings, exceeding analyst estimates, and announced a quarterly dividend of $1.452 per share.

Allworth Financial LP increased its stake in Parker-Hannifin Corporation by 11.8% in Q2, acquiring an additional 1,598 shares. This brings their total holdings to 15,111 shares, valued at $14.78 million. Other institutional investors have also adjusted their positions in the company, while a VP recently sold 602 shares.

Allianz Asset Management GmbH has made a new investment of $5.87 million in Standard Motor Products, Inc. (NYSE:SMP) by purchasing 150,613 shares. Other institutional investors like BlackRock Inc. and California State Teachers Retirement System also increased their stakes. Insiders have recently sold shares, while analysts have given the stock a "Moderate Buy" consensus rating with an average target price of $49.00.

Ameritas Advisory Services LLC significantly increased its stake in Netflix, Inc. ($NFLX) by 162.7% in the second quarter, bringing its total holdings to 49,078 shares valued at $3.5 million. This news comes alongside other institutional investors adjusting their positions in Netflix, while some analysts view the recent sell-off as a buying opportunity, despite concerns like insider selling and a South African pricing investigation. The article also details recent insider sales by Netflix CFO Spencer Neumann and David A. Hyman, and provides updated analyst price targets and the company's latest financial performance.

Amundi increased its stake in VICI Properties Inc. by 21.1% in the second quarter, purchasing over 1.34 million shares, bringing its total holding to 7.73 million shares valued at approximately $205.2 million. VICI Properties reported mixed quarterly results with revenue up but EPS missing consensus estimates, and the stock is trading near its 52-week low despite a recent dividend increase. Analysts maintain an overall "Hold" rating for the REIT, with an average price target of $31.